Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wanming Hu

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
The American Journal of Surgical Pathology|August 6, 2024
Spinal Cord Astroblastoma With EWSR1-BEND2 Fusion in Female Patients : A Report of Four Cases From China and a Comprehensive Literature ReviewLingyi Fu, I Weng Lao, Liyun Huang, et al.
International Journal of Biological Sciences|January 22, 2019
Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinomaXueping Wang, Minjie Mao, Zhonglian He, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 12, 2024
PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting PrognosisMin Xiong, Zhenghe Chen, Chao Zhou, et al.
International Journal of Oncology|February 6, 2016
Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracilJunpu Wang, Wanming Hu, Kuansong Wang, et al.
Frontiers in Oncology|October 7, 2022
Clinical implications of immune checkpoint markers and immune infiltrates in patients with thymic neuroendocrine neoplasmsMan Liu, Wanming Hu, Yixuan Zhang, et al.
International Journal of Oncology|March 18, 2016
CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylationJunpu Wang, Wanming Hu, Xiaoying Wu, et al.
The American Journal of Pathology|December 13, 2021
Weakly Supervised Framework for Cancer Region Detection of Hepatocellular Carcinoma in Whole-Slide Pathologic Images Based on Multiscale Attention Convolutional Neural NetworkSonghui Diao, Yinli Tian, Wanming Hu, et al.
Genomics|December 5, 2021
The enhanced cell cycle related to the response to adjuvant therapy in pancreatic ductal adenocarcinomaYize Mao, Weisheng Cheng, Qiuxia Yang, et al.
International Journal of Oncology|May 11, 2023
[Corrigendum] CXCR1 promotes malignant behavior of gastric cancer cells <i>in vitro</i> and <i>in vivo</i> in AKT and ERK1/2 phosphorylationJunpu Wang, Wanming Hu, Xiaoying Wu, et al.
Frontiers in Immunology|August 22, 2025
Pathological regression patterns following neoadjuvant chemo-immunotherapy in head and neck squamous cell carcinoma: a pilot studyDikan Wang, Fanning Zeng, Sien Zhang, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
The American Journal of Surgical Pathology|August 6, 2024
Spinal Cord Astroblastoma With EWSR1-BEND2 Fusion in Female Patients : A Report of Four Cases From China and a Comprehensive Literature ReviewLingyi Fu, I Weng Lao, Liyun Huang, et al.
International Journal of Biological Sciences|January 22, 2019
Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinomaXueping Wang, Minjie Mao, Zhonglian He, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 12, 2024
PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting PrognosisMin Xiong, Zhenghe Chen, Chao Zhou, et al.
International Journal of Oncology|February 6, 2016
Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracilJunpu Wang, Wanming Hu, Kuansong Wang, et al.
Frontiers in Oncology|October 7, 2022
Clinical implications of immune checkpoint markers and immune infiltrates in patients with thymic neuroendocrine neoplasmsMan Liu, Wanming Hu, Yixuan Zhang, et al.
International Journal of Oncology|March 18, 2016
CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylationJunpu Wang, Wanming Hu, Xiaoying Wu, et al.
The American Journal of Pathology|December 13, 2021
Weakly Supervised Framework for Cancer Region Detection of Hepatocellular Carcinoma in Whole-Slide Pathologic Images Based on Multiscale Attention Convolutional Neural NetworkSonghui Diao, Yinli Tian, Wanming Hu, et al.
Genomics|December 5, 2021
The enhanced cell cycle related to the response to adjuvant therapy in pancreatic ductal adenocarcinomaYize Mao, Weisheng Cheng, Qiuxia Yang, et al.
International Journal of Oncology|May 11, 2023
[Corrigendum] CXCR1 promotes malignant behavior of gastric cancer cells <i>in vitro</i> and <i>in vivo</i> in AKT and ERK1/2 phosphorylationJunpu Wang, Wanming Hu, Xiaoying Wu, et al.
Frontiers in Immunology|August 22, 2025
Pathological regression patterns following neoadjuvant chemo-immunotherapy in head and neck squamous cell carcinoma: a pilot studyDikan Wang, Fanning Zeng, Sien Zhang, et al.
Pageof 8